Weekly Spotlight - 07.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

New Drug Offers Hope for Multiple Myeloma Patients

Through foundational research, the Leukemia & Lymphoma Society (LLS) identified CD38 as a target for blood cancer treatment, resulting in FDA approval of isatuximab for multiple myeloma. This drug enhances survival rates, providing hope for patients, and LLS continues funding research to improve remission rates and quality of life.

BCMA Levels: Predicting Myeloma Risk, Severity, and Treatment Response

BCMA levels play a critical role in predicting multiple myeloma risk and response to treatment. Higher levels signal a greater therapy need, especially in active cases. This simple test enables personalized treatment decisions, aiding patients with multiple myeloma and related conditions like Waldenström macroglobulinemia.

Living with Myeloma: Stories of Resilience and Hope

Living with myeloma requires adapting to its relapsing nature. Patients like Joan, Louise, Ian, Cecelia, and Craig share their coping mechanisms, from exercise to emotional support. Their stories underscore community resilience and positive mindset as vital to navigating life with this illness.

Lessons from a Gay Man's Journey with Blood Cancer

A gay man with blood cancer shares his experience, emphasizing the value of community and self-care. Despite challenges, he finds comfort in support networks and symbols like rainbow lanyards. His journey highlights the importance of mental health and open communication in managing a cancer diagnosis.